Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
235 Cards in this Set
- Front
- Back
energy that is emitted by an atom and travels through space
|
Radiation
|
|
These are negatively charged subatomic particles that can be accelerated by a variety of machines or emitted from decaying isotopes and used for external beam treatment and brachytherapy.
|
Electron
|
|
What type of energy is used for superficial tumors or tumor beds
|
Electron
|
|
This is a small packet of electromagnetic radiation traveling through space at the speed of light (in a vacuum). It has no mass or electrical charge
|
Photon
|
|
these treat deep-seated tumors
|
Photon
|
|
in a linear accelerator ______ are accelerated and they can hit a target to produce _______ to be used for treating tumors or the ______ don’t hit the target and continue on so we can treat with them
|
electrons
photons electron |
|
These are verification films taken on the first day of treatment and typically once every 5 treatments (facility dependent). They are not for diagnostic use, but for localization purposes only to verify that the patient is lining up properly with each treatment.
|
Port films
|
|
for multiple field treatments, obliques, IMRT; we take take two images at a 90-degree angle from one another (typically AP and a LAT) to verify isocenter
|
Orthogonal imaging
|
|
provides the light tight conditions necessary for x-ray film and intensifying screens to work properly. It opens like a book, is made of material with a low atomic number such as cardboard, plastic or carbon fiber.
|
Cassette
|
|
this is located on each side of the inner part of the cassette
|
intensifying screen
|
|
this is placed between the intensifying screens for imaging
|
film
|
|
This is made of lead or other backing material to prevent unwanted scatter radiation from returning to the film once it has exited the cassette
|
the back of cassette
|
|
These are the simulation films or DRR's (digitally reconstructed radiograph), used as the baseline film to compare port films to. Indicates location of isocenter in patient
|
Reference images
|
|
what is DRR
|
digitally reconstructed radiograph
|
|
This is the removal of photons and electrons from a radiation beam by scatter or absorption as it travels through a medium, typically tissue or tissue equivalent material
|
Attenuation
|
|
– a distinct part of the linear accelerator that allows treatment field shaping and blocking through the use of motorized leaves in the head of the machine. Can reduce or eliminate the use of Cerrobend blocks
|
Multileaf collimator (MLC)
|
|
tissue equivalent material that is usually placed on the patient to increase the skin dose and/or even out irregular contours in the patient. When bolus is placed on the skin surface for MV radiation, skin sparing is lost.
|
bolus
|
|
a beam modifier that attenuates the beam across a field. Provides a better dose distribution
|
wedge
|
|
The _____ end of the wedge attenuates the greatest amount of radiation
|
heel
|
|
Wedge sizes – ___, ___, ___ and ___. Their orientation is designated by the ___; example: a 45-in indicates that the ___ of the wedge is positioned in to the gantry head.
|
Wedge sizes – ___, ___, ___ and ___. Their orientation is designated by the ___; example: a 45-in indicates that the ___ of the wedge is positioned in to the gantry head.
15, 30, 45, and 60 heel heel |
|
____ is the radiation beam size and dimensions
|
collimation
|
|
this is called the isocentric technique. Provides tumor localization in three dimensions
|
SAD set-ups
|
|
This is placed within the target volume with the aid of fluoroscopy and other imaging modalities
|
isocenter
|
|
This positions a fixed treatment distance of 100cm on the patient’s skin for each field.
|
SSD set-ups
|
|
This method requires repositioning the patient for each field before treatment. It usually uses a single field, two laterals or an AP/PA treatment. The field arrangement requires tumor localization in two dimensions only, because all tissues within these fields are treated and the exact depth of the tumor is not critical.
|
SSD set-ups
|
|
This field size is defined on the surface of the patient’s skin
|
SSD set-up
|
|
It is the central portion of the beam emanating from the target; the only part of the beam that is not divergent. In treatment plans with multiple fields, this part of each beam is directed toward the isocenter
|
central axis
|
|
This is the point of intersection of the three axes of rotation (gantry, collimator and base of couch) of the treatment unit
|
isocenter
|
|
This should be considered a reference point in space, a fixed distance (100cm) from the focal spot (source of x-ray production).
|
isocenter
|
|
This is the geometrical definition of the position and extent of the tumor or anatomic structures by reference of surface marks that can be used for treatment setup purposes
|
localization
|
|
This is a final check that makes sure each of the planned treatment beams does cover the tumor or target volume and does not irradiated critical normal structures.
|
verification
|
|
A Simm Verification or Block Check being done prior to the first treatment to ensure proper patient positioning is considered
|
verification....uh, this question doesnt really make sence, just memorize the shit casue it was in our handout
|
|
the measurement of the thickness of a patient along the central axis or at any other specified point within the irradiated field.
|
Separation
|
|
You use a caliper to find patients _______
|
Separation
|
|
This is the dimensions of a treatment field at the isocenter, which are represented by width x length.
|
Field Size
|
|
This is a machine designated to assist the physician and therapist in the treatment planning process.
|
Simulator
|
|
This is where we start with the patient to set-up positioning and immobilization devices and treatment parameters
|
Simulation
|
|
This projects a scale onto the patient’s skin, which corresponds to the SSD used during simulation or treatment
|
Optical Distance Indicator – (ODI)
|
|
What is ODI
|
Optical Distance Indicator
|
|
This is the most common combined-field geometry in which two treatment fields share common central axes, 180 degrees apart. Example: AP/PA
|
Parallel opposed (POP)
|
|
What is POP
|
Parallel opposed
|
|
This is the energy absorbed per unit mass of any material; units are the centigray (cGY) or rad (older term) (100 ergs per gram) or gray (1 Gy = 1 joule per kilogram).
1 Gy = 100 cGy or 100 rads |
Absorbed dose
|
|
This is the distance between the patient’s skin and the point of calculation
|
Depth
|
|
This is produced when an x-ray photon interacts with an outer-shell orbital electron with sufficient energy to eject it from orbit and alter its own path
|
Scatter
|
|
This is the depth at which electronic equilibrium occurs for photon beams. This is also the depth of maximum absorbed dose and ionization for photons, from a single treatment field.
|
Dmax
|
|
What is the Dmax for:
4 MV 6 MV 10 MV 18 MV 24 MV |
4 MV 1.0 cm
6 MV 1.5 cm 10 MV 2.5 cm 18 MV 3.5 cm 24 MV 4.0 cm |
|
This is referred to as the dose rate of the machine. Dose rate should be specified for field size, distance and medium
|
Output
|
|
This also known as output. It is the dose rate of a treatment machine. It is the amount of radiation exposure produced by a treatment machine or source as specified at a reference field size and at a specified reference distance
|
Dose rate
|
|
This is a unit of output used for linear accelerators. The accelerators are calibrated so that one MU delivers 1 cGy for a standard. The reference field size is a standard reference depth at a standard source to calibration point
|
Monitor Units
|
|
To figure this, we must consider the prescribed dose, output, reference dose rate
percent depth dose, tray factor, wedge factor |
Monitor Units
|
|
What is the formula for finding the monitor units
|
MU = Prescribed Dose(cGy)
_________________________ Output (cGy/MU) x Output factor x PDD x Tray factor |
|
This is therapy that delivers nonuniform exposure across the beam’s eye view using a variety of techniques and equipment
|
IMRT – (Intensity Modulated Radiation Therapy)
|
|
What is IMRT
|
Intensity Modulated Radiation Therapy
|
|
This is the ratio, expressed as a percentage, of the absorbed dose at a given depth to the absorbed dose at a fixed reference depth, usually Dmax
|
Percent depth dose
|
|
This is the spreading out of the beam of radiation. The farther from the source, the more the beam has spread. We need to be aware of beam this when setting up adjacent fields or where field edges are near critical structures. This part of the beam is taken into account when performing field size calculations and many dose calculations
|
Divergence
|
|
/PA to ~ 4500 cGy followed by POP oblique fields that are off-cord
|
Lung
|
|
This type of cancer recieves medial and lateral tangentials followed by an electron scar/tumor bed boost
|
Breast
|
|
: most places are using IMRT, however you may also see it as a 4-field pelvis (AP/PA and RT/LT Lats) or conformal therapy (4 obliques and RT/LT lats)
|
Prostate
|
|
typically a 4-field pelvis
|
GYN
|
|
What are the field arrangements for an abdomen
|
AP and PA
|
|
LATS, LATS with an AP Yoke field, use boost fields to come off-cord
|
Head and Neck
|
|
What is the field arrangements for a whole brain
|
Rt and Lt Lats
|
|
What is the field arrangements for a brain
|
Most places use IMRT
|
|
What is the field arrangements for a spine
|
typically single PA field, patient prone
|
|
Thisis the field arrangement for what? The patient is prone, PA and RT/LT LATS
|
Rectum
|
|
Field aarrangement for an extremity is typically.....
|
AP and PA
|
|
This field arrangement typically uses AP/PA followed by obliques off-cord
|
Esophagus
|
|
What part of the Linac contains the monitor & distributing “stuff” to the magnetron or klystron
|
modulator cabinet
|
|
What part of the Linac contains the primary electrical power and
high-voltage pulses |
modulator cabinet
|
|
What part of the Linac contains the noisiest componant
|
modulator cabinet
|
|
What part of the Linac contains the Klystron/Magnetron
Circulator Waveguide Cooling System |
drive stand
|
|
This is the device that produces microwaves
(really small wavelength 10E-6) where the electrons “spiral out” from the inner cathode to outer anode radiating energy in the form of microwaves. its used in low energy Linacs |
magnetron
|
|
What part of a LINAC is this decribing and where would it be housed? Electrons from cathode are accelerated by a negative pulse of voltage into the “buncher”
Incoming low-power microwaves setup an alternating electric field across the cavity which alters the velocity of the electrons. The electron bunches arrive at “catcher” and induce charges on the ends of the cavity retarding the electric field |
Klystron
Housed in the drive stand |
|
This is placed between the klystron and waveguide
and prevents “reflected” microwaves from returning |
Circulator
|
|
This is a hollow accordion-looking tube-like structure
that “Guides” the microwaves to the accelerator structure in the gantry |
Waveguide
|
|
These parts of the LINAC are housed in the _______
Electron Gun (gridded gun) Accelerator structure Treatment head Bending Magnet Tungsten Target |
Gantry
|
|
These parts of the LINAC are housed in the ______
Primary collimators Beam-flattening filter Target/scattering foil Ion chambers Field light Secondary Collimators MLCs Slots for beam-shaping & modifying devices |
Gantry
|
|
MU
|
monitor units
|
|
HDR
|
high dose rate brachytherapy
|
|
LDR
|
low doase rate brachytherapy
|
|
Blk
|
block custom
|
|
Bo
|
bolus
|
|
Col (with the little angle symbol that my computer wont do cause its a piece)
|
collimation angle
|
|
Gan (with the little angle symbol that my computer wont do cause its a piece)
|
gantry angle
|
|
FS
|
field size
|
|
SUP
|
superior
|
|
INF
|
inferior
|
|
SSD
|
Source-to-skin- distance
|
|
SSD
|
Source-to-skin- distance
|
|
SSN
|
Supra-sternal notch
|
|
SSN
|
Supra-sternal notch
|
|
SCF
|
Supraclavicular fossa
|
|
SCF
|
Supraclavicular fossa
|
|
Sep
|
Separation/thickness
|
|
Sep
|
Separation/thickness
|
|
SFD
|
Source-to film distance
|
|
SSD
|
Source-to-skin- distance
|
|
SFD
|
Source-to film distance
|
|
ABD
|
Abdomen
|
|
ABD
|
Abdomen
|
|
BAS
|
Barium Swallow
|
|
SSN
|
Supra-sternal notch
|
|
BAS
|
Barium Swallow
|
|
Ba
|
Barium
|
|
SCF
|
Supraclavicular fossa
|
|
AP
|
Anterio-Posterior
|
|
Ba
|
Barium
|
|
AP
|
Anterio-Posterior
|
|
Sep
|
Separation/thickness
|
|
ALARA
|
As Low As Reasonably Achievable.
|
|
ALARA
|
As Low As Reasonably Achievable.
|
|
SFD
|
Source-to film distance
|
|
ABD
|
Abdomen
|
|
BAS
|
Barium Swallow
|
|
Ba
|
Barium
|
|
AP
|
Anterio-Posterior
|
|
ALARA
|
As Low As Reasonably Achievable.
|
|
BE
|
Barium Enema
|
|
CEU
|
Continuing Education Unit
|
|
CAU
|
Caudal
|
|
ANC
|
Absolute neutrophil count
|
|
AML
|
Acute Myeloid leukaemia
|
|
AJCC
|
American Joint Committee on Cancer
|
|
ALL
|
Acute lymphoblastic leukaemia
|
|
BCC
|
Basal Cell Carcinoma
|
|
BM
|
Bone Marrow
|
|
BID
|
Twice a day
|
|
BMT
|
Bone Marrow Transplant
|
|
Ca
|
Cancer; carcinoma
|
|
C/W
|
Continue With
|
|
C/O
|
Complaining of
|
|
Bx
|
Biopsy
|
|
BSE
|
Breast Self Examination
|
|
BSA
|
Body Surface Area
|
|
cc
|
Cubic centimeter
|
|
CEA
|
Carcinoembryonic Antigen
|
|
CGL
|
Chronic Granulocytic Leukaemia
|
|
CMV
|
Cytomegalo virus
|
|
CPR
|
Cardio pulmonary resuscitation
|
|
CNS
|
Central nervous system - the brain and spine
|
|
cGy
|
Centi Gray
|
|
CLL
|
Chronic lymphocytic Leukaemia
|
|
CML
|
Chronic myeloid leukaemia
|
|
FU
|
Follow up
|
|
GA
|
General Anaesthetic
|
|
GPR
|
Good Partial Remission
|
|
GU
|
Genito-urinary
|
|
Gy
|
Grays
|
|
HL-A
|
Human Leukocyte Associated antigens (HL-A matching for BMT)
|
|
H/O
|
History of
|
|
HCC
|
Hepatocellular Carcinoma
|
|
HD
|
Hodgkin's Disease
or high dose |
|
HDC
|
High Dose Chemotherapy
|
|
HR
|
High risk
|
|
HRT
|
Hormone replacement therapy
|
|
I-131
|
Radioactive Iodine
|
|
ICD
|
International Classification of Diseases
|
|
IL2
|
Interleukin2
|
|
PFS
|
Progression Free Survival
|
|
PSA
|
prostate-specific antigen
|
|
PR
|
Partial Responce / Partial Remission
|
|
PH
|
Past History
|
|
QALY
|
Quality-Adjusted Life Year
|
|
RFS
|
Relapse free survival - Time from diagnosis to relapse or death.
|
|
QoL
|
Quality of Life
|
|
RCT
|
Randomised Controlled Trial
|
|
RNA
|
ribonucleic acid
|
|
RT
|
Radiotherapy
|
|
SD
|
Stable Disease
|
|
SCLC
|
Small cell lung cancer
|
|
SCC
|
Squamous Cell Carcinoma
|
|
SC
|
Subcutaneous
|
|
SAE
|
Serious Adverse Event
|
|
CHD
|
Coronary Heart Disease
|
|
ECG
|
Electro Cardiogram
|
|
DICOM
|
Digital Imaging and Communication in Medicine
|
|
OD
|
Optical Density
|
|
ADR
|
Adverse Drug Reaction
|
|
3DCRT
|
3 Dimensional Conformal Radiotherapy
|
|
TLD
|
Thermoluminescent Dosimeter
|
|
PACS
|
Picture Archive and Communications System
|
|
5-FU
|
5-Fluorouracil
|
|
ABMT
|
Autologous bone marrow transplant
|
|
CR
|
Complete remission / complete response
|
|
CRF
|
Chronic renal failure
|
|
CVC
|
Central venous catheters
|
|
CT
|
Chemotherapy
or computerized tomography |
|
D/C
|
Discharge
|
|
DFS
|
Disease Free Survival
|
|
DFI
|
Disease Free Interval
|
|
DDx
|
Differential diagnosis
|
|
D/H
|
Drug History
|
|
D/W
|
Discussed With
|
|
DCIS
|
Ductal Carcinoma In Situ
|
|
DI
|
Diabetes Incipidus
|
|
ECG
|
Electrocardiogram
|
|
EBV
|
Epstein-Barr Virus
|
|
ECOG
|
Eastern Cooperative Group
|
|
FNA
|
Fine Needle Aspiration
|
|
FFA
|
For Further Appointment
|
|
EFS
|
Event Free Survival
|
|
ENT
|
Ear nose throat
|
|
ETS
|
Environmental Tobacco Smoke
|
|
F/H
|
Family history
|
|
LCIS
|
Lobular Carcinoma In Situ
|
|
LN
|
Lymph Node
|
|
LP
|
Lumbar puncture
|
|
Lx
|
Lumpectomy
|
|
MDR
|
Multi drug resistant
|
|
MAB
|
Monoclonal antibody
|
|
M/H
|
Medical history
|
|
Mx
|
Mastectomy
|
|
NAD
|
No Abnormality Detected
|
|
NHL
|
Non Hodgkin's Lymphoma
|
|
NED
|
No evidence of disease
|
|
NK
|
Not known
|
|
NMR
|
Nuclear magnetic resonance
|
|
NOS
|
Not otherwise specified
|
|
PD
|
Progressive disease
|
|
OS
|
Overall Survival
|
|
NSCLC
|
Non-small cell lung cancer
|
|
NSR
|
Non significant result
|
|
O/E
|
On Examination
|
|
SGOT
|
Serum glutamic oxalacetic transaminase
|
|
SH
|
Social history
|
|
SGPT
|
Serum glutamic pyruvic transaminase
|
|
SWOG
|
Southwest Oncology Group
|
|
TBI
|
Total body irradiation
|
|
ULN
|
Upper Limits of Normal
|
|
Tx
|
Treatment
|
|
TNM
|
Staging system - primary tumor
|
|
TCP
|
Thrombocytopenia
|
|
TCC
|
Transitional Cell Carcinoma
|
|
WCC
|
White cell count
|
|
XRT
|
Radiotherapy (external)
|